3-[2-(1-methylpyrazol-4-yl)-4-pyridinyl]-4-(6-methyl-2-pyridinyl)-2,5-diazatricyclo[5.2.1.02,6]deca-3,5-diene
C23H22N6 — CID 134439695
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-[2-(1-methylpyrazol-4-yl)-4-pyridinyl]-4-(6-methyl-2-pyridinyl)-2,5-diazatricyclo[5.2.1.02,6]deca-3,5-diene
3-[2-(1-methylpyrazol-4-yl)-4-pyridinyl]-4-(6-methyl-2-pyridinyl)-2,5-diazatricyclo[5.2.1.02,6]deca-3,5-diene (PubChem CID 134439695) has the molecular formula C23H22N6 and a molecular weight of 382.47 g/mol. Its IUPAC name is 3-[2-(1-methylpyrazol-4-yl)-4-pyridinyl]-4-(6-methyl-2-pyridinyl)-2,5-diazatricyclo[5.2.1.02,6]deca-3,5-diene.
Molecular Properties
| Compound Name | 3-[2-(1-methylpyrazol-4-yl)-4-pyridinyl]-4-(6-methyl-2-pyridinyl)-2,5-diazatricyclo[5.2.1.02,6]deca-3,5-diene |
|---|---|
| PubChem CID | 134439695 |
| Molecular Formula | C23H22N6 |
| Molecular Weight | 382.47 g/mol |
| Exact Mass | 382.19 |
| IUPAC Name | 3-[2-(1-methylpyrazol-4-yl)-4-pyridinyl]-4-(6-methyl-2-pyridinyl)-2,5-diazatricyclo[5.2.1.02,6]deca-3,5-diene |
| SMILES | Cc1cccc(-c2nc3n(c2-c2ccnc(-c4cnn(C)c4)c2)C2CCC3C2)n1 |
| InChI | InChI=1S/C23H22N6/c1-14-4-3-5-19(26-14)21-22(29-18-7-6-16(10-18)23(29)27-21)15-8-9-24-20(11-15)17-12-25-28(2)13-17/h3-5,8-9,11-13,16,18H,6-7,10H2,1-2H3 |
| InChIKey | BPRNIBFKCRFPOU-UHFFFAOYSA-N |
| XLogP | 4.54 |
| TPSA | 61.42 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 382.47 |
| LogP ≤ 5 | 4.54 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 134439695 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.